Evolent Health Inc (NYSE: EVH) is -65.88% lower on its value in year-to-date trading and has touched a low of $10.53 and a high of $35.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EVH stock was last observed hovering at around $11.32 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $11.27, the stock is -3.07% and -30.87% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.66 million and changing -0.44% at the moment leaves the stock -52.69% off its SMA200. EVH registered -64.87% loss for a year compared to 6-month loss of -45.79%. The firm has a 50-day simple moving average (SMA 50) of $16.6208 and a 200-day simple moving average (SMA200) of $23.9354.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 0.18% gain in the last 1 month and extending the period to 3 months gives it a -59.31%, and is 3.68% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.22% over the week and 5.62% over the month.
Evolent Health Inc (EVH) has around 4700 employees, a market worth around $1.31B and $2.46B in sales. Fwd P/E is 11.72. Profit margin for the company is -4.23%. Distance from 52-week low is 7.03% and -67.80% from its 52-week high. The company has generated returns on investments over the last 12 months (-5.62%).
with sales reaching $652.18M over the same period.The EPS is expected to shrink by -28.91% this year, but quarterly earnings will post 30.34% year-over-year. Quarterly sales are estimated to grow 17.29% in year-over-year returns.
368.0 institutions hold shares in Evolent Health Inc (EVH), with institutional investors hold 118.71% of the company’s shares. The shares outstanding are 115.01M, and float is at 111.83M with Short Float at 8.73%. Institutions hold 114.03% of the Float.
The top institutional shareholder in the company is WELLINGTON MANAGEMENT GROUP LLP with over 11.17 million shares valued at $213.55 million. The investor’s holdings represent 9.785 of the EVH Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 11.06 million shares valued at $211.39 million to account for 9.6862 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 8.69 million shares representing 7.6108 and valued at over $166.1 million, while RA CAPITAL MANAGEMENT, L.P. holds 7.46 of the shares totaling 8.51 million with a market value of $162.8 million.
Evolent Health Inc (EVH) Insider Activity
The most recent transaction is an insider sale by McCarthy Daniel Joseph, the company’s PRESIDENT. SEC filings show that McCarthy Daniel Joseph sold 23,693 shares of the company’s common stock on Aug 22 ’24 at a price of $30.89 per share for a total of $0.73 million. Following the sale, the insider now owns 0.2 million shares.
Evolent Health Inc disclosed in a document filed with the SEC on Aug 23 ’24 that McCarthy Daniel Joseph (PRESIDENT) sold a total of 10,469 shares of the company’s common stock. The trade occurred on Aug 23 ’24 and was made at $32.38 per share for $0.34 million. Following the transaction, the insider now directly holds 0.19 million shares of the EVH stock.
Still, SEC filings show that on Aug 22 ’24, Weinberg Jonathan (General Counsel) disposed off 42,140 shares at an average price of $31.20 for $1.31 million. The insider now directly holds 167,027 shares of Evolent Health Inc (EVH).
